Detalhe da pesquisa
1.
Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE).
Am Heart J
; 235: 54-64, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33516752